Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-induced Neutropenia”

110 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 110 results

Testing effectiveness (Phase 2)Study completedNCT04345900
What this trial is testing

Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2

Who this might be right for
Chemotherapy-induced Neutropenia
BeyondSpring Pharmaceuticals Inc. 55
Testing effectiveness (Phase 2)Study completedNCT00364468
What this trial is testing

Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients

Who this might be right for
Neutropenia
Kyowa Kirin Co., Ltd. 107
Testing effectiveness (Phase 2)Study completedNCT01923545
What this trial is testing

Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia

Who this might be right for
Chemotherapy Induced Neutropenia
Dong-A ST Co., Ltd. 61
Large-scale testing (Phase 3)UnknownNCT03404752
What this trial is testing

Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.

Who this might be right for
Breast Cancer
Gema Biotech S.A. 120
Testing effectiveness (Phase 2)Study completedNCT00114764
What this trial is testing

Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)

Who this might be right for
Myeloid Leukemia
Amgen 84
Not applicableUnknownNCT03701841
What this trial is testing

Efficacy, Safety and Cost-effectiveness of PEG-rhG-CSF for Primary vs Secondary Prophylaxis

Who this might be right for
Chemotherapy-induced Neutropenia
Anhui Provincial Hospital 1,000
Large-scale testing (Phase 3)Study completedNCT03102606
What this trial is testing

Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3

Who this might be right for
Chemotherapy-induced Neutropenia
BeyondSpring Pharmaceuticals Inc. 105
Not applicableLooking for participantsNCT05245487
What this trial is testing

Danish Elder Lymphoma Patient Hematopoietic Investigation

Who this might be right for
LymphomaChemotherapy-induced NeutropeniaChemotherapy-Related Leukemia+1 more
Rigshospitalet, Denmark 300
Not applicableLooking for participantsNCT07192770
What this trial is testing

G-CSF-Induced Bone Pain and Supportive Care Approaches

Who this might be right for
Solid TumorsChemotherapy-induced Neutropenia
Ankara Etlik City Hospital 128
Not applicableApproved For MarketingNCT04504513
What this trial is testing

Expanded Access to Trilaciclib for Patients Receiving Chemotherapy for Small Cell Lung Cancer

Who this might be right for
Myelosuppression AdultChemotherapeutic ToxicitySmall Cell Lung Cancer
G1 Therapeutics, Inc.
Testing effectiveness (Phase 2)WithdrawnNCT00003407
What this trial is testing

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaMyelodysplastic Syndromes+1 more
Rush University Medical Center
Not applicableStudy completedNCT07113314
What this trial is testing

Prophylaxis of Febrile Neutropenia With Lactoferrin in Oncohematologic Children Undergoing Induction Chemotherapy

Who this might be right for
Febrile Neutropenia (FN)SepsisChemotherapy Treatment
Fondazione IRCCS Policlinico San Matteo di Pavia 160
Not applicableStudy completedNCT02428114
What this trial is testing

A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study)

Who this might be right for
Early Stage Breast Cancer
Ottawa Hospital Research Institute 142
Post-approval studies (Phase 4)Not Yet RecruitingNCT07320534
What this trial is testing

Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase

Who this might be right for
Neutropenic FeverAcute Lymphoblastic Leukemia
Gadjah Mada University 124
Large-scale testing (Phase 3)Ended earlyNCT00107081
What this trial is testing

Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting

Who this might be right for
FeverNeutropeniaCancer
Swiss Pediatric Oncology Group 70
Testing effectiveness (Phase 2)Ended earlyNCT00701870
What this trial is testing

Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Telik 1
Not applicableStudy completedNCT04460079
What this trial is testing

Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN

Who this might be right for
Chemotherapy-induced Neutropenia
Cinnagen 654
Large-scale testing (Phase 3)Active Not RecruitingNCT06711523
What this trial is testing

Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy

Who this might be right for
Neutropenia, Chemotherapy-Induced FebrileBreast Neoplasm Female
Kexing Biopharm Co., Ltd. 250
Not applicableStudy completedNCT01574235
What this trial is testing

Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents

Who this might be right for
Solid TumorsMalignant HemopathyChemotherapy-induced Febrile Neutropenia (FN)
Hospira, now a wholly owned subsidiary of Pfizer 2,114
Testing effectiveness (Phase 2)Ended earlyNCT04887831
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab

Who this might be right for
Urothelial CarcinomaBladder CancerMyelosuppression Adult+2 more
G1 Therapeutics, Inc. 92
Load More Results